3d
LOUISVILLE, Ky., Nov. 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud of its specialty pharmacy partner, Onco360 ®, ...
Onco360 ®, the nation’s leading independent specialty pharmacy, has been selected as a national pharmacy partner by Astellas for Vyloy ® (zolbetuximab-clzb), approved in combination with ...
Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Syndax ...
LOUISVILLE - Onco360, the nation's prominent independent specialty pharmacy, has been chosen as the national pharmacy partner for a suite of newly approved medications targeting advanced cancers and ...
“Onco360 is grateful for the opportunity to partner with the team at Astellas and become a specialty pharmacy provider for Vyloy ®,” said Benito Fernandez, Chief Commercial Officer.
Brightspring Health Services Announces Onco360® Has Been Selected As A Partner For Several New Drugs
Nov. 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring health Services (“BrightSpring” or“BrightSpring Health Services”) (NASDAQ: BTSG) is proud of its specialty pharmacy partner, Onco360®, for ...
(MENAFN- GlobeNewsWire - Nasdaq) LOUISVILLE, Ky., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation's leading independent specialty pharmacy, has been selected as a national pharmacy partner ...
“Onco360 is grateful for the opportunity to partner with the team at Astellas and become a specialty pharmacy provider for Vyloy ®,” said Benito Fernandez, Chief Commercial Officer. “We are proud to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback